Lizzul Paul F. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$373,637.74

Insider Activity of Lizzul Paul F.

According to the SEC Form 4 filings, Lizzul Paul F., being in a position of

  1. Chief Medical Officer at AnaptysBio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11604 shares for $521,526,
    over all time since 2023-09-14, has bought 0 shares, and sold 23483 shares for $895,164.

Biography of Lizzul Paul F.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $521,5264100

Comparison of Insiders on Amount of Buys and Sells

2026-01-08SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
3,650
0.0135%
$44.71$163,192+75.74%
2026-01-07SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
2,235
0.0081%
$45.11$100,821+70.11%
2026-01-05SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
4,219
0.0153%
$43.26$182,514+77.99%
2025-12-22SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
1,500
0.0054%
$50.00$75,000+51.42%
2024-09-23SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
1,500
0.0054%
$38.67$58,005-42.05%
2024-09-16SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
2,220
0.0074%
$38.93$86,425-46.75%
2024-08-14SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
2,000
0.0088%
$40.00$80,000-38.79%
2024-07-18SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
1,500
0.0056%
$35.00$52,500-37.48%
2024-01-08SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
2,554
0.0093%
$21.81$55,703+7.38%
2023-09-14SaleAnaptysBio, Inc.
ANAB
Chief Medical Officer
2,105
0.0079%
$19.48$41,005+19.22%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.